Clinical Trial Update: A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating weekly epoetin alfa (PROCRIT) versus placebo for anemia and quality of life in children receiving chemotherapy for cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hodgkin Lymphoma
• Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Ortho Biotech Products, L.P. | Conditions: Anemia, Hodgkin Disease | Phase 3 | Status: COMPLETED